Purple Biotech (PPBT) Times Interest Earned (2014 - 2026)
Purple Biotech (PPBT) posted quarterly Times Interest Earned of $72.61 for Q1 2026, up 80.76% year-over-year from $40.17 in Q1 2025, and down 33.72% quarter-over-quarter from $109.56 in Q4 2025.
Purple Biotech (PPBT) Times Interest Earned (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has reported Times Interest Earned for 12 consecutive years, with $72.61 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned rose 80.76% year-over-year to $72.61; the TTM figure through Mar 2026 stood at $102.91 (up 543.42% YoY), while the FY2025 annual figure was $27.96, up 22.72% from the prior year.
- Times Interest Earned retreated to $72.61 in Q1 2026 per PPBT's latest filing, from $109.56 in the prior quarter.
- Across five years, Times Interest Earned topped out at $366.72 in Q4 2022 and bottomed at -$14.72 in Q4 2024.
- Historically, Times Interest Earned has averaged $138.74 across 5 years, with a median of $86.81 in 2023.
- Annual changes were most pronounced in 2024 — Times Interest Earned tumbled 590.82% — and 2025, when it soared 6449.81%.
- Purple Biotech's Times Interest Earned stood at $366.72 in 2022, then plunged by 99.18% to $3.0 in 2023, then sank by 590.82% to -$14.72 in 2024, then surged by 844.06% to $109.56 in 2025, then plunged by 33.72% to $72.61 in 2026.
- Business Quant data shows PPBT's Times Interest Earned at $72.61 in Q1 2026, $109.56 in Q4 2025, and $273.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Purple Biotech | 130.35 | 130.35 | - | 144.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.61 |
| Dec 31, 2025 | 109.56 |
| Sep 30, 2025 | 273.40 |
| Jun 30, 2025 | 49.44 |
| Mar 31, 2025 | 40.17 |
| Dec 31, 2024 | -14.72 |
| Sep 30, 2024 | 4.17 |
| Jun 30, 2024 | 144.08 |
| Mar 31, 2024 | 262.71 |
| Dec 31, 2023 | 3.00 |
| Sep 30, 2023 | 359.19 |
| Jun 30, 2023 | 34.70 |
| Mar 31, 2023 | 86.81 |
| Dec 31, 2022 | 366.72 |
| Sep 30, 2022 | 317.56 |
| Jun 30, 2022 | 70.39 |
| Mar 31, 2022 | 178.80 |
| Dec 31, 2021 | 86.46 |
| Sep 30, 2021 | 144.86 |
| Jun 30, 2021 | 35.51 |